Reuters logo
BRIEF-Abiomed says enrolled first patient in FDA approved prospective feasibility study
May 4, 2017 / 11:25 AM / 5 months ago

BRIEF-Abiomed says enrolled first patient in FDA approved prospective feasibility study

May 4 (Reuters) - Abiomed Inc

* Abiomed - enrollment of first patient in fda approved prospective feasibility study, STEMI door to unloading with Impella CP system in acute myocardial infarction

* Abiomed Inc- Abiomed does not plan to announce additional enrollment status for study Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below